Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials by Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Charalampos-Vlasios Stikas, Alessandra Gennari, Bruno Vincenzi, Mark R. Openshaw, Marianna Silletta, Matthias Pinter, Alessio Cortellini, Lorenza Scotti, Antonio D’Alessio, David J. Pinato

Get full text

Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram by Agnese Losurdo, Agnese Losurdo, Angelo Dipasquale, Laura Giordano, Pasquale Persico, Pasquale Persico, Elena Lorenzi, Antonio Di Muzio, Antonio Di Muzio, Chiara Barigazzi, Chiara Barigazzi, James Korolewicz, Aman Mehan, Oreoluwa Mohammed, Benhard Scheiner, David J. Pinato, David J. Pinato, Armando Santoro, Armando Santoro, Matteo Simonelli, Matteo Simonelli

Get full text

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab by Simon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, Fabian Artusa, Bernhard Scheiner, Catherine Leyh, Sabine Lieb, Friedrich Sinner, Vincent Jörg, Thorben Fruendt, Vera Himmelsbach, Nada Abedin, Cennet Sahin, Katrin Böttcher, Jasmin Schuhbaur, Simon Labuhn, James Korolewicz, Claudia A.M. Fulgenzi, Antonio D'Alessio, Valentina Zanuso, Florian Hucke, Natascha Röhlen, Najib Ben Khaled, Eleonora Ramadori, Lukas Müller, Arndt Weinmann, Roman Kloeckner, Peter Robert Galle, Nguyen H. Tran, Sudhakar K. Venkatesh, Andreas Teufel, Matthias Ebert, Enrico N. De Toni, Dirk-Thomas Waldschmidt, Jens U. Marquardt, Dominik Bettinger, Markus Peck-Radosavljevic, Andreas Geier, Florian P. Reiter, Lorenza Rimassa, David J. Pinato, Christoph Roderburg, Thomas Ettrich, Michael Bitzer, Veit Scheble, Ursula Ehmer, Marie-Luise Berres, Fabian Finkelmeier, Maria Angeles Gonzalez-Carmona, Johann von Felden, Kornelius Schulze, Marino Venerito, Florian van Bömmel, Leonie S. Jochheim, Matthias Pinter, Raphael Mohr, Sumera I. Ilyas, Irene Schmidtmann, Friedrich Foerster

Get full text

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study by Nicholas Jones, Tarek Haykal, Noha Abdel-Wahab, Abdul Rafeh Naqash, Alessio Cortellini, Rana R McKay, Toni K Choueiri, Georgina V Long, Pauline Funchain, Sarah Abou Alaiwi, Amin H Nassar, Douglas B Johnson, Chul Kim, David J Pinato, Jonathan Trent, Vishal Navani, Alexandra Drakaki, Tomas G Neilan, Kaushal Parikh, Frank Aboubakar Nana, Eric H Yang, Elizabeth Anderson, Gavin Hui, Mingjia Li, Paul Sackstein, Shirly Grynberg, Jesus Antonio Ocejo Gallegos, Susan Dent, Ahmad Al-Hader, Ankita Tandon, Javier Baena, Yuki Kojima, Aakash P Desai, Arjun Mittra, Edward El-Am, Elie Kozaily, Rachel Woodford, Dory Freeman, Caleb Smith, Nausheen Akhter, Talal El Zarif, Ryan Denu, Walid Macaron, Alexi Vasbinder, Salim Hayeck, Rachel S Goodman, Ronnie Shapira, Jennifer M Kwan, Kan Yonemor, Alexandra Trevino, Elias Bou Farhat, Priyanka Babu, Mercedes Juarez Herrera, Simone Foderaro, James Korolewicz, Nerea Lopetegui-Lia, Arrush Choudhary, Aarti Asnani, Daniel Meyers, Igor Stukalin, Sanober Nusrat, Carmel Malvar

Get full text